Consolidated Statement Of Income

Immuno-Biological Laboratories Co., Ltd. - Filing #7325711

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Consolidated statement of income
Statement of income
Net sales
816,701,000 JPY
812,850,000 JPY
3,851,000 JPY
JPY
812,850,000 JPY
816,701,000 JPY
790,600,000 JPY
790,600,000 JPY
4,021,000 JPY
794,621,000 JPY
JPY
794,621,000 JPY
Cost of sales
298,004,000 JPY
299,408,000 JPY
266,400,000 JPY
267,908,000 JPY
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
56,520,000 JPY
46,920,000 JPY
Depreciation
1,970,000 JPY
JPY
Operating expenses
Selling, general and administrative expenses
402,203,000 JPY
412,993,000 JPY
453,706,000 JPY
469,564,000 JPY
Other
95,763,000 JPY
103,301,000 JPY
Operating expenses
Ordinary expenses
Other operating expenses
Share of loss of entities accounted for using equity method
JPY
203,844,000 JPY
Operating profit (loss)
104,299,000 JPY
107,816,000 JPY
-3,516,000 JPY
JPY
112,642,000 JPY
104,299,000 JPY
70,493,000 JPY
70,493,000 JPY
-13,344,000 JPY
57,148,000 JPY
JPY
57,148,000 JPY
Gross profit (loss)
514,846,000 JPY
517,293,000 JPY
524,199,000 JPY
526,712,000 JPY
Ordinary profit (loss)
145,815,000 JPY
125,413,000 JPY
65,973,000 JPY
-149,503,000 JPY
General and administrative expenses
Salaries
Operating expenses
Research and development expenses
130,474,000 JPY
129,983,000 JPY
180,151,000 JPY
180,151,000 JPY
Net sales
Cost of sales
Selling, general and administrative expenses
Legal welfare expenses
17,110,000 JPY
15,476,000 JPY
Bonuses
7,479,000 JPY
5,711,000 JPY
Supplies expenses
1,766,000 JPY
1,800,000 JPY
3,166,000 JPY
3,488,000 JPY
Non-operating income
Interest income
2,357,000 JPY
93,000 JPY
2,256,000 JPY
1,356,000 JPY
Other
2,931,000 JPY
4,394,000 JPY
2,120,000 JPY
5,616,000 JPY
Non-operating income
34,092,000 JPY
22,337,000 JPY
18,477,000 JPY
20,423,000 JPY
Extraordinary income
JPY
JPY
12,000 JPY
45,799,000 JPY
Extraordinary losses
21,590,000 JPY
769,000 JPY
688,147,000 JPY
176,908,000 JPY
Impairment losses
602,000 JPY
602,000 JPY
JPY
602,000 JPY
602,000 JPY
804,000 JPY
804,000 JPY
JPY
804,000 JPY
804,000 JPY
Non-operating expenses
Interest expenses
839,000 JPY
1,130,000 JPY
839,000 JPY
1,073,000 JPY
Other
80,000 JPY
93,000 JPY
566,000 JPY
566,000 JPY
Non-operating expenses
920,000 JPY
1,223,000 JPY
22,997,000 JPY
227,075,000 JPY
Profit (loss) before income taxes
124,225,000 JPY
124,644,000 JPY
-622,162,000 JPY
-280,611,000 JPY
Gross profit
Extraordinary income
Income taxes - current
5,438,000 JPY
5,857,000 JPY
8,806,000 JPY
9,119,000 JPY
Extraordinary losses
Income taxes - deferred
-67,908,000 JPY
-67,908,000 JPY
JPY
JPY
Income taxes
-62,469,000 JPY
-62,050,000 JPY
8,806,000 JPY
9,119,000 JPY
Profit (loss)
186,694,000 JPY
186,694,000 JPY
186,694,000 JPY
186,694,000 JPY
186,694,000 JPY
-630,968,000 JPY
-630,968,000 JPY
-630,968,000 JPY
-630,968,000 JPY
-289,731,000 JPY
Profit (loss) attributable to owners of parent
186,694,000 JPY
186,694,000 JPY
186,694,000 JPY
-289,731,000 JPY
-289,731,000 JPY
-289,731,000 JPY
Profit attributable to
Comprehensive income
186,694,000 JPY
-289,731,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
186,694,000 JPY
-289,731,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.